Teva Pharma (TEVA) calls more active than puts into Q3 and outlook
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $12.78 --0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +0.8%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +0.8%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) November call option implied volatility is at 87, December is at 46;compared to its 52-week range of 21 to 51 into Q3. November 42.50 and 45 calls are active on total call volume of 33K contracts (15K puts).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) April option implied volatility increases into quarter results
- Teucrium Corn Fund (CORN) call put ratio 18 calls to 1 put with focus on May 20 calls
- Lyft (LYFT) option IV increases
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
